Age (mean± SD) |
41.7±9.3 |
Hypertension (yes) |
13 (40.6%) |
Diabetes Mellitus (yes) |
9 (28%) |
ASA Score (II, III) |
16 (50%) |
Body mass index (BMI) (kg/m2) (median, range) |
27.6 (19–41) |
Stone former (yes) |
13 (40.6%) |
Previous stone surgery (yes) |
6 (18.75%) |
Preoperative ureteric stent (yes) |
8 (25%) |
Cause of preoperative stent
|
Tight ureter |
6 |
Obstructive uropathy / pain |
2 |
Preoperative serum creatinine (mg/dl) (median, range) |
0.95 (0.8–1.08) |
Preoperative eGFR (ml/min) (median, range) |
87 (43–100) |
Postoperative eGFR (ml/min) (median, range) |
91.5 (49–100) |
Preoperative Hb (gm/dl) (mean± SD) |
14.4±1.5 |
Postoperative Hb (gm/dl) (mean± SD) |
14.3±1.4 |
Hb deficit (gm/dl) (median, range) |
0.2 (-1.0-1.3) |
Laterality
|
Right |
13 (40.6%) |
Left |
19 (59.4%) |
Stone location
|
Renal pelvis |
32 (100%) |
Upper calyx |
10 (31.3%) |
Middle calyx |
21 (65.6%) |
Lower calyx |
28 (87.5%) |
Stone Morphology
|
Partial staghorn (renal pelvis and 1 calyx) |
10 (31.25%) |
Partial staghorn (renal pelvis and 2 calyces) |
14 (43.75%) |
Complete staghorn |
8 (25%) |
Secondary calyceal stones (yes) |
6 (18.75%) |
Stone width (mm) (median, range) |
22.2 (19.2–32.8) |
Stone length (mm) (median, range) |
20 (12–60) |
Stone volume (mm3) (median, range) |
7339 (3183–53,838) |
Stone density (HU) (mean± SD) |
1004 ± 342 |
Stone density
|
< 1000 |
13 (40.6%) |
≥ 1000 |
19 (59.4%) |
Chemical composition (available in 23 patients)
|
Calcium oxalate |
10 |
Uric acid |
6 |
Calcium phosphate |
1 |
Calcium oxalate + uric acid |
5 |
Calcium oxalate + Ca phosphate |
1 |